Clinical and clinicopathologic features of dogs that consumed foodborne hepatotoxic aflatoxins: 72 cases (2005–2006)
Search for other papers by Diane M. Dereszynski in
Current site
Google Scholar
PubMed
Search for other papers by Sharon A. Center in
Current site
Google Scholar
PubMed
Search for other papers by John F. Randolph in
Current site
Google Scholar
PubMed
Search for other papers by Marjory B. Brooks in
Current site
Google Scholar
PubMed
Search for other papers by Alice G. Hadden in
Current site
Google Scholar
PubMed
Search for other papers by Kiran S. Palyada in
Current site
Google Scholar
PubMed
Search for other papers by Sean P. McDonough in
Current site
Google Scholar
PubMed
Search for other papers by Joanne Messick in
Current site
Google Scholar
PubMed
Search for other papers by Tracy Stokol in
Current site
Google Scholar
PubMed
Search for other papers by Karyn L. Bischoff in
Current site
Google Scholar
PubMed
Search for other papers by Stuart Gluckman in
Current site
Google Scholar
PubMed
Search for other papers by Sara Y. Sanders in
Current site
Google Scholar
PubMed
Abstract
Objective—To characterize clinical signs, clinicopathologic features, treatments, and survival in dogs with naturally acquired foodborne aflatoxicosis.
Design—Retrospective case series.
Animals—72 dogs that consumed aflatoxin-contaminated commercial dog food.
Procedures—Medical records of affected dogs were reviewed. Between December 2005 and March 2006, dogs were identified as having foodborne aflatoxin hepatotoxicosis on the basis of the history of consumption of contaminated food or characteristic histopathologic lesions (subject dog or a recently deceased dog in the same household or kennel). Recorded information included signalment, clinical features, clinicopathologic test results, treatments, and survival. Data were analyzed by survival status.
Results—Most dogs were of large breeds from breeding kennels. No significant differences were found in age or weight between 26 (36%) survivor dogs and 46 (64%) nonsurvivor dogs. Severity of clinical signs varied widely; 7 dogs died abruptly. In order of onset, clinical features included anorexia, lethargy, vomiting, jaundice, diarrhea (melena, hematochezia), abdominal effusion, peripheral edema, and terminal encephalopathy and hemorrhagic diathesis. Common clinicopathologic features included coagulopathic and electrolyte disturbances, hypoproteinemia, increased serum liver enzyme activities, hyperbilirubinemia, and hypocholesterolemia. Cytologic hepatocellular lipid vacuolation was confirmed in 11 dogs examined. In comparisons of clinicopathologic test results between survivor and nonsurvivor dogs, only granular cylindruria (7/21 dogs) consistently predicted death. Best early markers of aflatoxicosis were low plasma activities of anticoagulant proteins (protein C, antithrombin) and hypocholesterolemia. Despite aggressive treatment, many but not all severely affected dogs died.
Conclusions and Clinical Relevance—Serum liver enzyme activities and bilirubin concentration were unreliable early markers of aflatoxin hepatotoxicosis in dogs. Hypocholesterolemia and decreased plasma protein C and antithrombin activities may function as exposure biomarkers.
| All Time | Past Year | Past 30 Days | |
|---|---|---|---|
| Abstract Views | 548 | 0 | 0 |
| Full Text Views | 2672 | 1127 | 117 |
| PDF Downloads | 810 | 321 | 19 |
- PubMed Citation
- Article by Diane M. Dereszynski
- Article by Sharon A. Center
- Article by John F. Randolph
- Article by Marjory B. Brooks
- Article by Alice G. Hadden
- Article by Kiran S. Palyada
- Article by Sean P. McDonough
- Article by Joanne Messick
- Article by Tracy Stokol
- Article by Karyn L. Bischoff
- Article by Stuart Gluckman
- Article by Sara Y. Sanders
- Similar articles in PubMed
